Cme (CME) Research & Development (2009 - 2026)

Cme (CME) has 18 years of Research & Development data on file, last reported at $76.6 million in Q1 2026.

• Research & Development for Q1 2026 came in at $76.6 million, up 16.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $294.1 million (up 12.21% YoY), and the FY2025 annual result was $283.2 million, up 10.71% from the prior year.
• Research & Development advanced to $76.6 million in Q1 2026 per CME's latest filing, from $75.2 million in the prior quarter.
• Over five years, Research & Development peaked at $76.6 million in Q1 2026 and troughed at $45.9 million in Q1 2022.
• A 5-year average of $60.2 million and a median of $59.4 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2024: Research & Development slipped 6.9% in 2022, then grew 20.26% in 2024.
• A 5-year view of Research & Development shows it stood at $50.0 million in 2022, then gained by 17.0% to $58.5 million in 2023, then grew by 12.31% to $65.7 million in 2024, then climbed by 14.46% to $75.2 million in 2025, then advanced by 1.86% to $76.6 million in 2026.
• Business Quant data shows CME's Research & Development at $76.6 million in Q1 2026, $75.2 million in Q4 2025, and $71.4 million in Q3 2025.